These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 1490666)
1. Recombinant human growth hormone and oxandrolone in treatment of short stature in girls with Turner syndrome. Stahnke N; Stubbe P; Keller E Horm Res; 1992; 37 Suppl 2():37-46. PubMed ID: 1490666 [TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human growth hormone therapy on bone and clinical parameters in girls with Turner's syndrome. The Spanish Collaborative Group. Ferrández A; Mayayo E; Arnal JM; García C; Buñuel C; Lasarte JJ; Anton R; Puyuelo P Acta Paediatr Scand Suppl; 1989; 356():87-91; discussion 92. PubMed ID: 2816362 [TBL] [Abstract][Full Text] [Related]
3. Combined therapy with growth hormone and oxandrolone in adolescent girls with Turner syndrome. Lu PW; Cowell CT J Paediatr Child Health; 1993 Feb; 29(1):40-2. PubMed ID: 8461179 [TBL] [Abstract][Full Text] [Related]
4. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial. Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249 [TBL] [Abstract][Full Text] [Related]
5. Recombinant growth hormone in children and adolescents with Turner syndrome. Cave CB; Bryant J; Milne R Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993 [TBL] [Abstract][Full Text] [Related]
7. Effect of oxandrolone on growth and final height in Turner's syndrome. Naeraa RW; Nielsen J; Pedersen IL; Sørensen K Acta Paediatr Scand; 1990; 79(8-9):784-9. PubMed ID: 2239273 [TBL] [Abstract][Full Text] [Related]
8. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. Rosenfeld RG; Frane J; Attie KM; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM J Pediatr; 1992 Jul; 121(1):49-55. PubMed ID: 1625092 [TBL] [Abstract][Full Text] [Related]
9. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. Stahnke N; Keller E; Landy H; J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177 [TBL] [Abstract][Full Text] [Related]
10. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone. Bareille P; Massarano AA; Stanhope R Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976 [TBL] [Abstract][Full Text] [Related]
11. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone. van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome]. Li J; Wu W; Liang Y; Luo XP Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213 [No Abstract] [Full Text] [Related]
13. The effect of short-term growth hormone or low-dose oxandrolone treatment in boys with constitutional growth delay. Loche S; Pintor C; Cambiaso P; Lampis A; Carta D; Corda R; Cappa M J Endocrinol Invest; 1991 Oct; 14(9):747-50. PubMed ID: 1761810 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters. Haeusler G; Frisch H Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078 [TBL] [Abstract][Full Text] [Related]
15. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. Rosenfeld RG; Hintz RL; Johanson AJ; Sherman B; Brasel JA; Burstein S; Chernausek S; Compton P; Frane J; Gotlin RW J Pediatr; 1988 Aug; 113(2):393-400. PubMed ID: 3397807 [TBL] [Abstract][Full Text] [Related]
16. Recombinant growth hormone for children and adolescents with Turner syndrome. Baxter L; Bryant J; Cave CB; Milne R Cochrane Database Syst Rev; 2007 Jan; (1):CD003887. PubMed ID: 17253498 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group. Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190 [TBL] [Abstract][Full Text] [Related]
18. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome. Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097 [TBL] [Abstract][Full Text] [Related]